Stocks
Health Care
zntl
Zentalis Pharmaceuticals
NASDAQ: ZNTL
+2.20 (+49.66%)
6.615
USD
At close at Apr 10, 20:43 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-258.62M
Pretax Income
-136.62M
Net Income
-165.84M
EBITDA
-164.37M
EBIT
-165.66M
Earnings Per Share
-2.3200000000000003
Balance Sheet
Cash & Cash Equivalents
40.11M
Total Debt
40.99M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
383.22M
Book Value Per Share
5.39
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.